Abstract
A cap binding complex activity was purified from HeLa cells by a procedure which does not depend on the use of cap-affinity chromatography. The activity co-purified with a Mr 220000 polypeptide (p220), but not with elF4A. The active complex therefore differs from eIF4F, the complex purified by cap analog-affinity chromatography, in that it lacks the Mr 50000 subunit which is antigenically identical to elF4A. The activities of elF4F, CBP I and the eIF4A free complex purified here were compared in a fractionated system translating capped globin mRNA. Results indicate that the two complexes have similar activities and that they perform a function which cannot be provided by CBP I alone. Cap binding complex activity can be partly separated from eIF4A activity on sucrose gradients, thus eIF4A provides a function that is distinct from cap binding complex activity. The results indicate that eIF4A can be physically separated from the cap binding complex without affecting the ability of the remaining structure to function in an in vitro translation system. They suggest that the eIF4A-free complex may provide a function that is not a property of either CBP I or of eIF4A, but may be a property of p220.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Shatkin A: MRNA cap binding proteins: Essential factors for initiating translation. Cell 40:223–224, 1985.
Sonenberg N, Morgan MA, Merrick WC, Shatkin AJ: A polypeptide in eukaryotic initiation factors that crosslinks specifically to the 5′-terminal cap in mRNA. Proc Natl Acad Sci USA 75:4843–4847, 1978
Edery I, Humbelin M, Darveau A, Lee KAW, Milburn S, Hershey JWB, Trachsel H, Sonenberg N: Involvement of eIF4A in the cap recognition process. J Biol Chem 258:11398–11403, 1983
Grifo JA, Tahara SM, Morgan MA, Shatkin AJ, Merrick WC: New initiation factor activity required for globin mRNA translation. J Biol Chem 258:5804–5810, 1983
Sonenberg N, Shatkin AJ: Reovirus mRNA can be covalently crosslinked via the 5′ cap to protein in initiation complexes. Proc Natl Acad Sci USA 74:4288–4292, 1977
Sonenberg N: ATP/Mg++-dependent crosslinking of cap binding protein to the 5′ end of eukaryotic mRNA. Nucleic Acids Res 9:1643–1656, 1981
Hellmann GM, Chu L-Y, Rhoads RE: A polypeptide which reverses cap analogue inhibition of cell-free protein synthesis. J Biol Chem 257:4056–4062, 1982
Lax S, Fritz W, Browning K, Ravel J: Isolation and characterization of factors from wheat germ that exhibit eukaryotic initiation factor 4B activity and overcome 7-methylguanosine 5′-triphosphate inhibition of polypeptide synthesis. Proc Natl Acad Sci USA 82:330–333, 1983
Rose JK, Trachsel H, Leong K, Baltimore D: Inhibition of translation by poliovirus. Inactivation of a specific initiation factor. Proc Natl Acad Sci USA 75:2732–2736, 1978
Tahara SM, Morgan MA, Shatkin AJ: Two forms of purified m7G-cap binding protein with different effects on capped mRNA translation in extracts of uninfected and poliovirus-infected HeLa cells. J Biol Chem 256:7691–7694, 1981
Hansen J, Ehrenfeld E: Presence of the cap binding protein in initiation factor preparations from poliovirus-infected HeLa cells. J Virol 38:438–445, 1981
Grifo JA, Tahara SM, Leis JP, Morgan MA, Shatkin AJ, Merrick WC: Characterization of eukaryotic initiation factor 4A, a protein involved in ATP-dependent binding of globin mRNA. J Biol Chem 257:5246–5252, 1982
Seal SM, Schmidt A, Marcur A: Eucaryotic initiation factor 4A is the component that interacts with ATP in protein chain initiation. Proc Natl Acad Sci USA 80:6562–6565, 1983
Tahara SM, Morgan MA, Shatkin AJ: Binding of inosinesubstituted mRNA to reticulocyte ribosomes and cukaryotic initiation factors 4A and 4B requires ATP. J Biol Chem 258:11350–11353, 1983
Ray BK, Lawson TG, Kramer JC, Cladaras MH, Grifo JA, Abramson RD, Merrick WC, Thach RE: ATP-dependent unwinding of messenger RNA structure by eukaryotic initiation factors. J Biol Chem 260:7651–7658, 1985
Duncan R, Etchison D, Hershey JWB: Initiation factors eIF4A and eIF4B are not altered by poliovirus infection of HeLa cells. J Biol Chem 258:7236–7239, 1983
Daniels-McQueen S, Detjen BM, Grifo JA, Merrick WC, Thach RE: Unusual requirements for optimum translation of polioviral RNA in vitro. J Biol Chem 258:7195–7199, 1983
Etchison D, Milburn S, Edery I, Sonenberg N, Hershey JWB: Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220000 dalton polypeptide associated with initiation factor eIF3 and a cap binding protein complex. J Biol Chem 257:14806–14810, 1982
Lee KAW, Edery I, Sonenberg N: Isolation and structural characterization of cap-binding proteins from poliovirus-infected HeLa cells. J Virol 54:515–524, 1985
Etchison D, Hansen J, Ehrenfeld E, Edery I, Sonenberg N, Milburn S, Hershey JWB: Demonstration in vitro that eucaryotic initiation factor 3 is active but that a cap-binding protein complex is inactive in poliovirus-infected cells. J Virol 51:832–837, 1984
Brown-Luedi ML, Meyer LJ, Milburn SC, Yau PM-P, Corbett S, Hershey JWB: Protein synthesis initiation factors from human HeLa cells and rabbit reticulocytes are similar: Comparison of protein structure, activities and immunochemical properties. Biochem 21:4202–4205, 1982
Benne R, Brown-Luedi ML, Hershey JWB: Protein synthesis initiation factors from rabbit reticulocytes: Purification, characterization and radiochemical labeling. Methods Enz 60:15–35, 1979
Helentjaris T, Ehrenfeld E, Brown-Luedi ML, Hershey JWB: Alteration in initiation factor activity from poliovirus-infected HeLa cells. J Biol Chem 254:10973–10978, 1979
Webb NR, Chari RVJ, DePillis G, Kozarich JW, Rhoads RE: Purification of the messenger RNA cap-binding protein using a new affinity medium. Biochem 23:177–181, 1984
Towbin H, Staehelin T, Gordon J: Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: Procedure and some applications. Proc Natl Acad Sci USA 76:4350–4354, 1979
Oakley BR, Kirsch DR, Morris NR: A simplified ultrasensitive silver stain for detecting proteins in polyacrylamide gels. Anal Biochem 105:361–363, 1980
Sonenberg N, Rupprecht KM, Hecht SM, Shatkin AJ: Eukaryotic mRNA cap binding protein: purification by affinity chromatography on Sepharose-coupled m7GDP. Proc Natl Acad Sci USA 76:4345–4349
Trachsel H, Sonenberg N, Shatkin AJ, Rose JK, Leong K, Bergman JE, Gordon J, Baltimore D: Purification of a factor that restores translation of vesicular stomatitis virus mRNA in extracts from poliovirus-infected HeLa cells. Proc Natl Acad Sci USA 77:770–774, 1980
Lloyd RE, Etchison D, Ehrenfeld E: Poliovirus protease does not mediate the cleavage of the 220000 dalton component of the cap binding protein complex. Proc Natl Acad Sci USA 82:2723–2727, 1985
Sarkar G, Edery I, Sonenberg N: Photoaffinity labeling of the cap-binding protein complex with ATP/dATP. J Biol Chem 260:13831–13837, 1985
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Etchison, D., Milburn, S. Separation of protein synthesis initiation factor eIF4A from a p220-associated cap binding complex activity. Mol Cell Biochem 76, 15–25 (1987). https://doi.org/10.1007/BF00219394
Issue Date:
DOI: https://doi.org/10.1007/BF00219394